ScreenerHero
SLBTSL Science Holding Limited Ordinary Shares
NAS · US · Healthcare · Biotechnology · sl-bio.com
2.742USD+2.70%Mkt Cap: 1.50B $P/E: —

SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate se…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
ARGENX SE
$60.19BUSDP/E 39.1
UCB
UCB SA
$45.16BUSDP/E 19.2
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.17BUSDP/E 26.2
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5
ARWR
Arrowhead Pharmaceuticals, Inc.
$12.59BUSD
HeadlineSourceTime
This week
SL Science Holding (SLBT) Stock May Be Fully Priced Even After A 74% Fall

SL Science Holding has experienced a steep share price decline so far this year, while current valuation checks suggest the stock does not screen as a clear bargain. Year to date the share price is down 73.9%, which indicates that sentiment around SL Science Holding has weakened sharply. Future revenue and cash flow expectations can still support the share price if the business executes well. However, any setback in funding or clinical and product development may weigh heavily on what...

Simply Wall St.
Older
Sector Update: Healthcare Stocks Decline Late Afternoon

Healthcare stocks were lower late Friday afternoon, with the NYSE Healthcare Index decreasing 0.7% a

MMT Newswires
Top Midday Decliners

SL Science (SLBT) reported a 2025 net loss late Thursday that was wider than a year earlier amid a d

MMT Newswires